by Dorothée PISU | Mar 15, 2021 | Article
Bionobis signs a new agreement with one of the world leaders specializing in the manufacture of devices to fight against Covid-19. Bionobis is positioned on the PRE-ANALYTICAL and ANALYTICAL market by presenting a complete range of MDs (for oropharyngeal /...
by makedifferent | Jan 28, 2021 | Article
Bionobis launches the new DigitalTRACE ™ range on the market for the study of post-graft chimerism With our experience, we support laboratories moving towards Genotyping and Monitoring in Digital PCR technique. Our complete solution consists of InDel markers and...
by makedifferent | Nov 19, 2020 | Article
New Activity Discover our products Bionobis has recently designed and developed an innovative system for HLA genotyping by the NGS technique. Our NanoStar® system offers a fully automated workflow, HLA typing kits and dedicated analysis...
by makedifferent | Jul 26, 2020 | Article
QMS ISO 13485 Bionobis is ISO 13485 : 2016 certification in...
Recent Comments